Codexis analyst coverage
WebApr 5, 2024 · According to analysts' consensus price target of $18.83, Codexis has a forecasted upside of 356.0% from its current price of $4.13. Amount of Analyst … WebBased on analysts offering 12 month price targets for CDXS in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .
Codexis analyst coverage
Did you know?
WebApr 6, 2024 · Codexis presently has a consensus price target of $18.83, indicating a potential upside of 362.74%. Icosavax has a consensus price target of $22.50, indicating a potential upside of 254.89%. Given Codexis' higher possible upside, equities research analysts plainly believe Codexis is more favorable than Icosavax.
WebApr 6, 2024 · Company Overview. Codexis, Inc. (Nasdaq: CDXS) is a leading enzyme engineering company that applies its technology to discover and develop novel, high performance enzymes and biotherapeutics. Codexis enzymes have applications in the sustainable manufacturing of small molecule pharmaceuticals, in RNA and DNA … WebJun 1, 2024 · New Research Coverage Highlights WPP, Codexis, Natural Resource Partners LP, Mercer International, Booking, and SINOPEC Shangai Petrochemical — Consolidated Revenues, Company Growth, and ...
WebFeb 28, 2024 · There are some variant perceptions on Codexis, with the most bullish analyst valuing it at US$29.00 and the most bearish at US$21.00 per share. ... (with … WebApr 13, 2024 · Codexis ( NASDAQ:CDXS – Get Rating) last issued its quarterly earnings results on Thursday, February 23rd. The biotechnology company reported ($0.19) EPS …
WebApr 9, 2024 · Analyst Upgrades and Downgrades. A number of equities research analysts have weighed in on the company. Piper Sandler lifted their target price on Codexis from $22.00 to $23.00 and gave the stock ...
WebJan 6, 2016 · In a report issued Wednesday, analysts at H.C. Wainwright initiated coverage on Codexis, a micro cap company that develops high-efficiency biocatalysts, with a Buy rating and $6.00 price target. simply vera vera wang platinum beddingWebApr 6, 2024 · Company Overview. Codexis, Inc. (Nasdaq: CDXS) is a leading enzyme engineering company that applies its technology to discover and develop novel, high … simply vera vera wang cocktail dressesWebJul 28, 2024 · The latest analyst coverage could presage a bad day for Codexis, Inc. ( NASDAQ:CDXS ), with the analysts making... rayymen technologies private limitedWebApr 10, 2024 · What is Codexis's consensus rating and price target? According to the issued ratings of 3 analysts in the last year, the consensus rating for Codexis stock is Buy based on the current 3 buy ratings for CDXS. The average twelve-month price prediction for Codexis is $18.83 with a high price target of $23.00 and a low price target of $9.00. simply vera vera wang purseWebFeb 27, 2024 · Following the latest downgrade, the six analysts covering Codexis provided consensus estimates of US$76m revenue in 2024, which would reflect a sizeable 45% … rayynor silva wifeWebApr 5, 2024 · Analysts Have Just Cut Their Codexis, Inc. (NASDAQ:CDXS) Revenue Estimates By 10% Jul 28. Codexis: Profitability, Return On Capital Are Persistent Headwinds Looking Ahead Jul 27. Codexis, Inc. Announces CEO Changes, Effective August 9, 2024. ... Help Center Latest Coverage Podcasts Affiliate Program. rayynor silva weddingWebFeb 27, 2024 · Following the latest downgrade, the six analysts covering Codexis provided consensus estimates of US$76m revenue in 2024, which would reflect a sizeable 45% decline on its sales over the past 12 ... ray yoga center naugatuck ct